I-507

Immunosuppressants CRM in Human Whole Blood (K2EDTA) solution

50-2000 ng/mL (Human Whole Blood (K2EDTA)), certified reference material, vial of 3 mL, Cerilliant^®

• UNSPSCコード: 41116107
• NACRES: NA.77

特性

• グレード: certified reference material
• 品質水準: 300
• 特徴: Snap-N-Spike^®/Snap-N-Shoot^®
• 組成: Cyclosporin A, 2000 ng/mL ; Everolimus, 50 ng/mL ; Sirolimus, 50 ng/mL ; Tacrolimus, 50 ng/mL
• 包装: vial of 3 mL
• メーカー／製品名: Cerilliant^®
• 濃度: 50-2000 ng/mL (Human Whole Blood (K2EDTA))
• フォーマット: multi-component solution
• 保管温度: −70°C

詳細

詳細

A Certified Spiking Solution^® of routinely tested Immunosuppressants including Cyclosporin A, Everolimus, Sirolimus and Tacrolimus at concentrations of 50-2000 ng/mL in Human Whole Blood. Immunosuppressants are drugs that inhibit or prevent the activity of the immune system and are routinely tested in clinical LC-MS/MS testing applications. This multi-component matrix mix from Cerilliant^® is suitable for critical quantitative applications in research and clinical environments including: for use in preparation of controls, calibrators, and linearity standards for LC-MS/MS assays; as system tuning/suitability standards; linearity verification; and internal proficiency testing. The stable, quantitative solution format in Human Whole Blood matrix provides significant benefits to the user such as convenience of use, material savings, increased efficiency of labor and reduced matrix effects. Certified concentration values for each component provides increased efficiency from less time remaking pools due to dilution errors or rerunning samples.

法的情報

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

安全性情報

• 保管分類コード: 12 - Non Combustible Liquids
• WGK: WGK 1
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable